Award information
Criteria
The technology that lies at the heart of this award does not have to be proven, but it will, in the eyes of the Voting Panel, be innovative, well funded, and capable of significant commercial success. The technology concerned could have been developed within the organisation or acquired.
2024 Winner
2024 Shortlist
- 4basebio plc
- Avacta Group plc
- BiVictriX Therapeutics plc
- Creo Medical Group plc
- CRISPR Therapeutics AG
- MaxCyte, Inc.